Contribute Try STAT+ Today

Hello, everyone, and how are you today? We are doing just fine, thank you, as the Pharmalot campus settles into a familiar routine. The short person is, once again, hovering over a nearby laptop and the official mascot is bounding about the grounds in search of varmints. As for us, we are busy brewing cups of stimulation and organizing our calendar, for what that is worth. Meanwhile, here are a few tidbits to help you on your journey. We hope you have a productive day and conquer the world. Stay in touch and stay safe — wear a mask. …

The Food and Drug Administration is warning health care workers that any changes to the authorized dosing schedules of Covid-19 vaccines currently being administered would significantly place public health at risk and undermine “the historic vaccination effort to protect the population” from the coronavirus pandemic, NPR tells us. The FDA reacted to suggestions that the number of limited doses could be stretched by cutting them in half, extending the length of time between doses, or mixing and matching vaccines to immunize more people.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.